Paper9020150
Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis.
Dolan M and 3 others. J Biol Chem, 1997. Cited by 96 papers, by iCite.
Cite this record
ConductScience Library. Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis. Papers, record 9020150. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9020150
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heparan Sulfate Proteoglycans | Major topic |
| Heparan Sulfate | Major topic |
| Proteoglycans | Major topic |
| Amino Acid Sequence | |
| Animals | |
| COS Cells | |
| DNA, Complementary | |
| Mice | |
| Molecular Sequence Data | |
| Recombinant Proteins | |
| Transfection |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 GM45380 | NIGMS NIH HHS | United States | R01GM045380 | PubMed and NIH |
Source NIH RePORTER
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41699623 | Early hypoxia-induced secretome remodeling reveals adaptive mechanisms and biomarkers of blood-brain barrier dysfunction in ischemic stroke. | Mol Brain | 2026 | https://conductscience.org/library/papers/41699623 | PubMed |
| 40340918 | The glycosaminoglycan chains of perlecan regulate the perivascular fluid transport. | Fluids Barriers CNS | 2025 | https://conductscience.org/library/papers/40340918 | PubMed |
| 39930241 | Critical Roles of SEA Domains. | Adv Exp Med Biol | 2025 | https://conductscience.org/library/papers/39930241 | PubMed |
| 38424183 | Dyssegmental dysplasia Rolland-Desbuquois type is caused by pathogenic variants in HSPG2 - a founder haplotype shared in five patients. | J Hum Genet | 2024 | https://conductscience.org/library/papers/38424183 | PubMed |
| 37828045 | Molecular mechanism of decision-making in glycosaminoglycan biosynthesis. | Nat Commun | 2023 | https://conductscience.org/library/papers/37828045 | PubMed |
| 36577752 | Regulation of stem cell fate by HSPGs: implication in hair follicle cycling. | NPJ Regen Med | 2022 | https://conductscience.org/library/papers/36577752 | PubMed |
| 35537467 | Genetic Disorders of the Extracellular Matrix: From Cell and Gene Therapy to Future Applications in Regenerative Medicine. | Annu Rev Genomics Hum Genet | 2022 | https://conductscience.org/library/papers/35537467 | PubMed |
| 34876200 | Basal lamina changes in neurodegenerative disorders. | Mol Neurodegener | 2021 | https://conductscience.org/library/papers/34876200 | PubMed |
| 32484111 | The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target. | Curr Neuropharmacol | 2020 | https://conductscience.org/library/papers/32484111 | PubMed |
| 32010611 | Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan. | Front Oncol | 2019 | https://conductscience.org/library/papers/32010611 | PubMed |
| 31968632 | Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/31968632 | PubMed |
| 31338215 | Basement membrane and blood-brain barrier. | Stroke Vasc Neurol | 2019 | https://conductscience.org/library/papers/31338215 | PubMed |
| 30453502 | Modular Proteoglycan Perlecan/HSPG2: Mutations, Phenotypes, and Functions. | Genes (Basel) | 2018 | https://conductscience.org/library/papers/30453502 | PubMed |
| 30226080 | Basement membrane and stroke. | J Cereb Blood Flow Metab | 2019 | https://conductscience.org/library/papers/30226080 | PubMed |
| 26308067 | Determinants of Glycosaminoglycan (GAG) Structure. | Biomolecules | 2015 | https://conductscience.org/library/papers/26308067 | PubMed |
| 25751786 | Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard? | Molecules | 2015 | https://conductscience.org/library/papers/25751786 | PubMed |
| 25575808 | The non glycanated endocan polypeptide slows tumor growth by inducing stromal inflammatory reaction. | Oncotarget | 2015 | https://conductscience.org/library/papers/25575808 | PubMed |
| 21890498 | A valid mouse model of AGRIN-associated congenital myasthenic syndrome. | Hum Mol Genet | 2011 | https://conductscience.org/library/papers/21890498 | PubMed |
| 18596265 | Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation. | Circ Res | 2008 | https://conductscience.org/library/papers/18596265 | PubMed |
| 18570250 | Dynamic expression patterns of ECM molecules in the developing mouse olfactory pathway. | Dev Dyn | 2008 | https://conductscience.org/library/papers/18570250 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9020150
GET https://conductscience.org/api/papers/v1/9020150/cited_by?page=2